Company intelligence / Profile preview

Suan Biotech FCR

Castanheira do Ribatejo, Portugal

Ownership: Private
Development stage: Other

Overview

Suanfarma operates through its R&D division Innovasuan, focusing on developing generic APIs and off-patent pharmaceuticals. The company emphasizes non-infringing synthesis routes, GMP-compliant analytical methods, and regulatory filings. They partner with CDMOs/CMOs for API development and have facilities meeting international regulatory standards.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Suan Biotech FCR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suan Biotech FCR.

Explore the full profile